These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 8033152

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.
    Varley JM, Brammar WJ, Lane DP, Swallow JE, Dolan C, Walker RA.
    Oncogene; 1991 Mar; 6(3):413-21. PubMed ID: 2011397
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Mutations in the p53 gene in primary human breast cancers.
    Osborne RJ, Merlo GR, Mitsudomi T, Venesio T, Liscia DS, Cappa AP, Chiba I, Takahashi T, Nau MM, Callahan R.
    Cancer Res; 1991 Nov 15; 51(22):6194-8. PubMed ID: 1682043
    [Abstract] [Full Text] [Related]

  • 28. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P, Rathore A, Mathur M, Sarkar C, Mahapatra AK, Sinha S.
    Oncogene; 1997 Aug 14; 15(7):871-4. PubMed ID: 9266974
    [Abstract] [Full Text] [Related]

  • 29. Expression of p53 and 17p allelic loss in colorectal carcinoma.
    Cunningham J, Lust JA, Schaid DJ, Bren GD, Carpenter HA, Rizza E, Kovach JS, Thibodeau SN.
    Cancer Res; 1992 Apr 01; 52(7):1974-80. PubMed ID: 1551126
    [Abstract] [Full Text] [Related]

  • 30. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR, Spruck CH, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T, Jones PA.
    Cancer Res; 1996 Nov 01; 56(21):5039-43. PubMed ID: 8895761
    [Abstract] [Full Text] [Related]

  • 31. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T, Nomura N, Mori H, Wake N.
    Gynecol Oncol; 1996 Nov 01; 63(2):173-9. PubMed ID: 8910623
    [Abstract] [Full Text] [Related]

  • 32. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
    Kittiniyom K, Mastronardi M, Roemer M, Wells WA, Greenberg ER, Titus-Ernstoff L, Newsham IF.
    Genes Chromosomes Cancer; 2004 Jul 01; 40(3):190-203. PubMed ID: 15138999
    [Abstract] [Full Text] [Related]

  • 33. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S, Mohren K, Knuechel R, Wild PJ, Burger M, Wieland WF, Hartmann A, Stoehr R.
    Hum Pathol; 2006 Feb 01; 37(2):143-51. PubMed ID: 16426913
    [Abstract] [Full Text] [Related]

  • 34. Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions.
    Cornelis RS, Devilee P, van Vliet M, Kuipers-Dijkshoorn N, Kersenmaeker A, Bardoel A, Khan PM, Cornelisse CJ.
    Oncogene; 1993 Mar 01; 8(3):781-5. PubMed ID: 8437862
    [Abstract] [Full Text] [Related]

  • 35. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.
    Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413
    [Abstract] [Full Text] [Related]

  • 36. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
    Futreal PA, Cochran C, Marks JR, Iglehart JD, Zimmerman W, Barrett JC, Wiseman RW.
    Cancer Res; 1994 Apr 01; 54(7):1791-4. PubMed ID: 7511052
    [Abstract] [Full Text] [Related]

  • 37. p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma.
    Adesina AM, Nalbantoglu J, Cavenee WK.
    Cancer Res; 1994 Nov 01; 54(21):5649-51. PubMed ID: 7923211
    [Abstract] [Full Text] [Related]

  • 38. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
    Prosser J, Thompson AM, Cranston G, Evans HJ.
    Oncogene; 1990 Oct 01; 5(10):1573-9. PubMed ID: 2250913
    [Abstract] [Full Text] [Related]

  • 39. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.
    Takita K, Sato T, Miyagi M, Watatani M, Akiyama F, Sakamoto G, Kasumi F, Abe R, Nakamura Y.
    Cancer Res; 1992 Jul 15; 52(14):3914-7. PubMed ID: 1617666
    [Abstract] [Full Text] [Related]

  • 40. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lindblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacius S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM, Larsson C.
    Cancer Res; 1998 Mar 01; 58(5):1004-12. PubMed ID: 9500463
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.